Marshall Wace’s Trevi Therapeutics TRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.6M | Sell |
2,477,916
-76,305
| -3% | -$417K | 0.02% | 655 |
|
|
2025
Q1 | $16.1M | Buy |
2,554,221
+2,511,300
| +5,851% | +$15.8M | 0.02% | 539 |
|
|
2024
Q4 | $177K | Sell |
42,921
-38,203
| -47% | -$157K | ﹤0.01% | 2210 |
|
|
2024
Q3 | $271K | Buy |
+81,124
| New | +$271K | ﹤0.01% | 2028 |
|
|
2022
Q4 | – | Sell |
-128,324
| Closed | -$198K | – | 2840 |
|
|
2022
Q3 | $198K | Buy |
+128,324
| New | +$198K | ﹤0.01% | 2345 |
|
|
2022
Q2 | – | Sell |
-23,402
| Closed | -$52K | – | 3181 |
|
|
2022
Q1 | $52K | Buy |
+23,402
| New | +$52K | ﹤0.01% | 2512 |
|